Abstract  Description  Claims  Search report  Cited references 

WO2001049340A   [0017] 

A new X-ray contrast compound, lanthanum orthotantalate, and its possible use in abdominal surgery   [0011] 
Experience in application of oil-based contrast agents   [0011] 
Selected chapters of bronchography   [0011] 
The examination of digestive tract with new modification of Barium sulfats   [0011] 
Prevention of complications in lymphangiography   [0011] 
Prevention of complications in X-ray examination using contrast agents   [0011] 
Neurotoxicity of X-ray contrast agents // Pharmacology and Toxicology   [0011] 
Sodium versus meglumine diatrizoate in excretory urography   [0011] 
The influence of contrast medium dose on filtration fraction in the rabbit kidney   [0011] 
Persistence of the hydralazine syndrome   [0011] 
Adverse reactions to contrast agents   [0011] 
Challenges of development and application of X-ray contrast agents in oncology   [0012] 
Magnetic resonance imaging in medical practice   [0012] 
Contrast agents   [0013] 
Rare earth compounds with monoatomic and polyatomic anions of group V transition metals   [0013] 
A new X-ray contrast agent for bronchography   [0013] 
X-ray contrast agents: composite oxides of group III-V elements (yttrium orthotantalate)   [0013]